 |
InterPro: IPR001295 Dihydroorotate dehydrogenase, conserved site
Additional Reading
|
|
Hurt DE, Widom J, Clardy J.
Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor.
Acta Crystallogr. D Biol. Crystallogr. 62 2006 312-23
[PubMed: 16510978]
http://dx.doi.org/10.1107/S0907444905042642
|
|
Wolfe AE, Thymark M, Gattis SG, Fagan RL, Hu YC, Johansson E, Arent S, Larsen S, Palfey BA.
Interaction of benzoate pyrimidine analogues with class 1A dihydroorotate dehydrogenase from Lactococcus lactis.
Biochemistry 46 2007 5741-53
[PubMed: 17444658]
http://dx.doi.org/10.1021/bi7001554
|
|
Walse B, Dufe VT, Svensson B, Fritzson I, Dahlberg L, Khairoullina A, Wellmar U, Al-Karadaghi S.
The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites.
Biochemistry 47 2008 8929-36
[PubMed: 18672895]
http://dx.doi.org/10.1021/bi8003318
|
|
Baumgartner R, Walloschek M, Kralik M, Gotschlich A, Tasler S, Mies J, Leban J.
Dual binding mode of a novel series of DHODH inhibitors.
J. Med. Chem. 49 2006 1239-47
[PubMed: 16480261]
http://dx.doi.org/10.1021/jm0506975
|
|
Hurt DE, Sutton AE, Clardy J.
Brequinar derivatives and species-specific drug design for dihydroorotate dehydrogenase.
Bioorg. Med. Chem. Lett. 16 2006 1610-5
[PubMed: 16406782]
http://dx.doi.org/10.1016/j.bmcl.2005.12.029
|
|
|
InterPro 23.1
|